The U.S. Food and Drug Administration issued a marketing denial order for blu Disposable Classic Tobacco 2.4%, an e-cigarette product manufactured by Fontem US, the agency announced. “This means the company still must not market or distribute this product in the United States, or they risk enforcement action by FDA. The company may submit a new application for the product subject to this MDO,” the FDA stated. Publicly traded companies in the tobacco products space include Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM).
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTI:
- Cautious Outlook on British American Tobacco Amid Market Challenges and Preference for Imperial Brands
- British American Tobacco price target raised to $40 from $35.50 at Morgan Stanley
- British American Tobacco price target raised to 3,300 GBp from 2,800 GBp at JPMorgan
- British American Tobacco price target raised to 4,450 GBp at Citi
- British American Tobacco price target raised to 4,400 GBp from 4,200 GBp at Deutsche Bank